Invega sustenna and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported as a side effect among people who take Invega sustenna (paliperidone palmitate), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Seroquel, and have Schizoaffective disorder bipolar type.

The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Invega sustenna. It is created by eHealthMe based on reports of 23,130 people who have side effects when taking Invega sustenna from the FDA, and is updated regularly.

What is Invega sustenna?

Invega sustenna has active ingredients of paliperidone palmitate. It is often used in schizophrenia. eHealthMe is studying from 23,232 Invega sustenna users. Check the latest studies of Invega sustenna.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,408 drugs and 3,131 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

On Jul, 18, 2026

23,130 people reported to have side effects when taking Invega sustenna.
Among them, 16 people (0.07%) have Haemoglobin decreased.

Could Invega sustenna cause Haemoglobin decreased?

Among these 16 people:

How long have people been on Invega sustenna when they have Haemoglobin decreased? *

What is the gender of people who have Haemoglobin decreased when taking Invega sustenna? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Haemoglobin decreased when taking Invega sustenna? *

What are other drugs people take besides Invega sustenna? *

What are other side effects people have besides Haemoglobin decreased? *

Weight Decreased: 5 people, 31.25%
Muscle Spasms (muscle contraction): 3 people, 18.75%
Haematocrit Decreased: 3 people, 18.75%
Dehydration (dryness resulting from the removal of water): 3 people, 18.75%
Rashes (redness): 3 people, 18.75%
Agitation (state of anxiety or nervous excitement): 2 people, 12.50%
Peripheral Swelling: 2 people, 12.50%
Heart Rate Decreased: 2 people, 12.50%
Diabetes: 2 people, 12.50%
Drowsiness: 2 people, 12.50%

What are the existing conditions these people have? *

Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 3 people, 18.75%
Affective Disorder (mental disorder): 2 people, 12.50%
Stress And Anxiety: 1 person, 6.25%
Schizoaffective Disorder Depressive Type (mental illness featuring schizophrenia and a mood disorder): 1 person, 6.25%
Muscle Aches (muscle pain): 1 person, 6.25%
Joint Pain: 1 person, 6.25%
Emotional Disorder: 1 person, 6.25%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 1 person, 6.25%
Bipolar Disorder (mood disorder): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Invega sustenna and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invega sustenna:

Invega sustenna (23,232 reports)

Browse all side effects of Invega sustenna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin decreased:

Haemoglobin decreased (2,408 drugs)

Browse all the conditions that are associated with Haemoglobin decreased:

Haemoglobin decreased (3,131 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Invega sustenna) and Invega sustenna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.